Myoferlin gene silencing decreases Tie-2 expression in vitro and angiogenesis in vivo

Carol Yu, Arpeeta Sharma, Andy Trane, Soraya Utokaparch, Cleo Leung, Pascal Bernatchez

Research output: Contribution to journalArticleResearchpeer-review

29 Citations (Scopus)

Abstract

Angiogenesis consists in the growth of new blood vessels from pre-existing ones. Although anti-angiogenesis interventions have been shown to have therapeutic properties in human diseases such as cancer, their effect is only partial and the identification of novel modulators of angiogenesis is warranted. Recently, we reported the unexpected proteomic identification in endothelial cells (EC) of Myoferlin, a member of the Ferlin family of transmembrane proteins. Ferlins are well known to regulate the fusion of lipid vesicles at the plasma membrane in muscle cells, and we showed that Myoferlin gene knockdown not only decreases lipid vesicle fusion in EC but also attenuates Vascular Endothelial Growth Factor (VEGF) Receptor-2 (VEGFR-2) expression.Herein, we show that Myoferlin gene silencing in cultured EC also results in attenuated expression of a second tyrosine kinase receptor, Tie-2, which is another well-described angiogenic receptor. Most importantly, we provide evidence that delivery of a low-volume Myoferlin siRNA preparation in mouse tissues results in attenuated angiogenesis and edema formation. This provides the first evidence that acute Myoferlin knockdown has anti-angiogenic effects and validates Myoferlin as an anti-angiogenesis target. Furthermore, this supports the unexpected but increasingly accepted concept that proper tyrosine kinase receptors expression at the plasma membrane requires Myoferlin.

Original languageEnglish
Pages (from-to)26-33
Number of pages8
JournalVascular Pharmacology
Volume55
Issue number1-3
DOIs
Publication statusPublished - Jul 2011
Externally publishedYes

Keywords

  • Angiogenesis
  • Myoferlin
  • Tie-2

Cite this